Follow
Andrei Seferian
Andrei Seferian
Université Paris-Sud, Hôpital Bicêtre, AP-HP, Inserm UMR-S999, 78 Rue du Général Leclerc, Le Kremlin-Bicêtre 94270, France
Verified email at bct.aphp.fr - Homepage
Title
Cited by
Cited by
Year
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
C Guignabert, C Phan, A Seferian, A Huertas, LY Tu, R Thuillet, C Sattler, ...
The Journal of clinical investigation 126 (9), 3207-3218, 2016
2552016
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
AM Hoffmann-Vold, TM Maher, EE Philpot, A Ashrafzadeh, R Barake, ...
The Lancet Rheumatology 2 (2), e71-e83, 2020
2442020
Pathogenesis of pulmonary arterial hypertension: lessons from cancer
C Guignabert, L Tu, M Le Hiress, N Ricard, C Sattler, A Seferian, ...
European Respiratory Review 22 (130), 543-551, 2013
2192013
Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle–like cells in pulmonary hypertension
N Ricard, L Tu, M Le Hiress, A Huertas, C Phan, R Thuillet, C Sattler, ...
Circulation 129 (15), 1586-1597, 2014
1992014
Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension
S Günther, X Jaïs, S Maitre, A Berezne, P Dorfmüller, A Seferian, L Savale, ...
Arthritis & Rheumatism 64 (9), 2995-3005, 2012
1552012
Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension
S Günther, X Jaïs, S Maitre, A Berezne, P Dorfmüller, A Seferian, L Savale, ...
Arthritis & Rheumatism 64 (9), 2995-3005, 2012
1552012
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
D Montani, B Girerd, X Jaïs, M Levy, D Amar, L Savale, P Dorfmüller, ...
The Lancet Respiratory Medicine 5 (2), 125-134, 2017
1522017
Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
A Beurnier, EM Jutant, M Jevnikar, A Boucly, J Pichon, M Preda, M Frank, ...
European Respiratory Journal 56 (5), 2020
1262020
Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?
A Seferian, G Simonneau
European Respiratory Review 22 (129), 217-226, 2013
1192013
Pulmonary arterial hypertension in patients treated with interferon
L Savale, C Sattler, S Günther, D Montani, MC Chaumais, S Perrin, X Jaïs, ...
European Respiratory Journal 44 (6), 1627-1634, 2014
1152014
Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
J Weatherald, MC Chaumais, L Savale, X Jaïs, A Seferian, M Canuet, ...
European Respiratory Journal 50 (1), 2017
1132017
Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease
D Montani, EM Lau, A Descatha, X Jaïs, L Savale, P Andujar, ...
European Respiratory Journal 46 (6), 1721-1731, 2015
1132015
Drug-induced pulmonary arterial hypertension: a recent outbreak
D Montani, A Seferian, L Savale, G Simonneau, M Humbert
European Respiratory Review 22 (129), 244-250, 2013
1132013
Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension
A Boucly, L Savale, X Jaïs, F Bauer, E Bergot, L Bertoletti, A Beurnier, ...
American journal of respiratory and critical care medicine 204 (7), 842-854, 2021
1112021
Ventilation/perfusion lung scan in pulmonary veno-occlusive disease
A Seferian, B Helal, X Jaïs, B Girerd, LC Price, S Günther, L Savale, ...
European Respiratory Journal 40 (1), 75-83, 2012
742012
Ventilation/perfusion lung scan in pulmonary veno-occlusive disease
A Seferian, B Helal, X Jaïs, B Girerd, LC Price, S Günther, L Savale, ...
European Respiratory Journal 40 (1), 75-83, 2012
742012
Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?
L Godinas, C Guignabert, A Seferian, F Perros, E Bergot, Y Sibille, ...
Seminars in respiratory and critical care medicine 34 (05), 714-724, 2013
732013
Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
M Jevnikar, O Sanchez, R Chocron, M Andronikof, M Raphael, ...
European Respiratory Journal 58 (1), 2021
662021
Dasatinib increases endothelial permeability leading to pleural effusion
C Phan, EM Jutant, L Tu, R Thuillet, A Seferian, D Montani, A Huertas, ...
European Respiratory Journal 51 (1), 2018
602018
Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity
M Riou, A Seferian, L Savale, MC Chaumais, C Guignabert, M Canuet, ...
European Respiratory Journal 48 (5), 1517-1519, 2016
582016
The system can't perform the operation now. Try again later.
Articles 1–20